Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung

7680669310011 CH-66931 Injektionslösung
Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/08/2023
Patient information leaflet
Français
03/08/2023
Patient information leaflet
Italien
03/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
162.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1063.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2019

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
66931
Drug name
Actemra, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Galenic form
LSPA
ATC Code
L04AC07
Authorization status
Z
Dispensing category
A
First authorization
10/12/2018
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Riesenzellarteriitis, polyartikuläre juvenile idiopathische Arthritis, systemische juvenile idiopathische Arthritis

Package details

Description (FR)
ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
Description (DE)
ACTEMRA Inj Lös 162 mg/0.9 ml Fertigpen 4 Stk
Market launch
10/12/2018
Narcotic (BTM)
No